In univariate COX proportional hazards analysis, cancer patients positive for SHOX2 and/or SEPT9 methylation showed a significantly worse outcome compared to patients with methylation-negative cellular DNA (HR = 1.63; p = 0.039, Table 5). This evidence concerns the gene SHOX2 and cancer.